Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.
Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...
Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...
Elevance Health ELV -2.57% + Free Alerts has outperformed the market over the past 15 years by 2.24% on an annualized basis producing an average annual return of 13.22%. Currently, Elevance Health has ...
Shares of Elevance Health Inc. ELV shed 2.61% to $411.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 ...
We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...
Blue Cross Blue Shield was hit with six federal antitrust suits on the day of the deadline for health care provider class ...
Meanwhile, a suit filed against Cigna in California says the insurer denied over 300,000 claims in two months—about 1.2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results